Literature DB >> 3146901

MHC class I and II gene expression on human tumors.

F Ruiz-Cabello1, M A Nevot, F Garrido.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3146901     DOI： 10.1007/978-1-4899-5037-6_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

Review 1.  Targeting inhibitory pathways in cancer immunotherapy.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Curr Opin Immunol       Date:  2010-05-12       Impact factor: 7.486

2.  A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast.

Authors:  S Minafra; V Morello; F Glorioso; A M La Fiura; R M Tomasino; S Feo; D McIntosh; D E Woolley
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

3.  K-ras mutations and HLA-DR expression in large bowel adenomas.

Authors:  S Norheim Andersen; J Breivik; T Løvig; G I Meling; G Gaudernack; O P Clausen; A Schjölberg; O Fausa; F Langmark; E Lund; T O Rognum
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

4.  MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.

Authors:  F Esteban; M Redondo; M Delgado; F Garrido; F Ruiz-Cabello
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 5.  Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression.

Authors:  Ying Zhang; Hildegund C J Ertl
Journal:  Front Immunol       Date:  2016-02-10       Impact factor: 7.561

6.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

Authors:  S N Andersen; T O Rognum; E Lund; G I Meling; S Hauge
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.